Evaluation of a preprimed microporous hollow-fiber membrane for rapid response neonatal extracorporeal membrane oxygenation

Abstract

Delays in initiating extracorporeal membrane oxygenation (ECMO) in the critically ill pediatric patient may lead to adverse outcomes. Maintaining a primed ECMO circuit can considerably reduce the initiation time. The predominant concerns precluding this practice are a decrease in oxygenator efficiency due to the saturation of microporous hollow fibers and compromised sterility when the oxygenator has been primed for 30 days. For institutions using a hollow-fiber oxygenator for ECMO, there are no data reporting pre-primed hollow-fiber oxygenator viability. This study reports the efficiency of oxygen transfer and the sterility of the Carmeda Minimax Plus (Medtronic, Inc, Minneapolis, MN) oxygenator after being crystalloid primed for 30 days. A total of 10 Minimax Plus oxygenators were tested for oxygen transfer in a laboratory setting utilizing fresh whole bovine blood. The control group (n=5) were tested immediately after priming. The test group (n=5) were oxygenators primed for 30 days with crystalloid solution and left stagnant until tested. Prior to testing, all oxygenators were circulated for 5 min and samples drawn to test for circuit sterility. Venous inlet saturations were manipulated to achieve three levels of testing: venous saturation (SvO₂) of 55% for an oxygen challenge, SvO₂ of 65% to comply with AAMI standards, and SvO₂ of 75% to assess oxygen transfer rates and peak PaO₂ achievement. Blood flow for all tests was maintained at 2 L/min with 1:1 blood to gas flow ratio and 100% FiO₂. Samples were drawn pre- and postoxygenator at 1- and 6-hour time intervals to compute actual oxygen transfer values. All cultures from the test group priming solution produced no microbial growth after 30 days of stagnant prime. Average oxygen transfer values (ml/O₂/min) for the control group after 1 hour of continuous use were 130.1±15.5 (@55% SvO₂), 113.7±10.4 (@65% SvO₂),97.7±8.9 (@75% SvO₂). After 6 hours, the average transfer values increased to 134.2±13.2 (@55% SvO₂), 118.76±6.6 (@65% SvO₂) and 98.9±8.3 (@75% SvO₂). The average oxygen transfer values after 1 hour for oxygenators primed for 30 days were 114.9±10.0 (@55% SvO₂), 112.4±8.2 (@65% SvO₂) and 89.6±16.0 (@75% SvO₂). After 6 hours of use, the average transfer values all decreased to 111.4±2.1 (@55% SvO₂, p <0.05 versus control), 104.0±5.6 (@65% SvO₂, p<0.05 versus control) and 88.4±3.2 (@75% SvO₂, p<0.05 versus control). In conclusion, there was a decrease in the average oxygen transfer values for the test group after 6 hours versus the control. The modest loss of oxygen transfer ability observed can be considered acceptable due to the amount of surface area of the Minimax Plus oxygenator when used on a neonate, making it feasible to adopt the practice of prepriming the Minimax oxygenator for neonatal ECMO.

Get full access to this article

View all access options for this article.

References

Kern F , Schulman S , Lawson DS , Darling EM. Extra-corporeal circulation and circulatory assist devices in the pediatric patient. In Lake CL ed. Pediatric cardiac anesthesia, third edition. Stamford, CT: Appleton and Lange , 1997: 219-258.

Hintz SR , Suttner DM , Sheehan AM et al. Decreased use of neonatal extracorporeal oxygenation (ECMO): how new treatment modalities have affected ECMO utilization . Pediatrics 2000; 106: 1339-1343 .

Kennaugh JM , Kinsella JP , Abman SH et al. Impact of new treatments for neonatal pulmonary hypertension on extracorporeal membrane oxygenation use and outcome . J Perinatol 1997; 17: 266-269 .

ECMO Registry Report of the Extracorporeal Life Support Organization. Ann Arbor, MI: Extracorporeal Life Support Organization, July 2004.

Lawson DS , Walczak R , Lawson AF et al. North American Neonatal Extracorporeal Membrane Oxygenation (ECMO) Devices: 2002 survey results . J Extra Corpor Technol 2004; 36: 16-21 .

Volcelka CR , Burdge EC , Junzelman KS , Thomas R , Vierrier ED. An in vitro protocol for evaluation and comparison of membrane oxygenators . J Extra Corpor Technol 1993; 25: 161-166 .

Van Meurs KP , Mikesell GT , Hearty JP , Seale WR , Rivera O , Short BL. In vitro testing of the 0.6 M2SciMed membrane oxygenator for use in neonatal extracorporeal membrane oxygenation . J Extra Corpor Technol 1991; 23: 49-53 .

AAMI/ANSI/ISO. Cardiovascular Implants and Artificial Organs, Blood Gas Exchangers (oxygenators), Document ANSI/AAMI/ISO 7199: 1996/(R)2002.

Hirschl RB. Devices. In Zwischenberger JB , Bartlett RH eds. Extracorporeal support in critical care, first edition. Ann Arbor, MI: Extracorporeal Life Support Organization , 1995: 159-190.

10.

Gao G , Stammers AH , Ahlgren RL et al. The effects of preprimed oxgenators on gas transfer efficiency . J Extra Corpor Technol 2003; 35: 121-126 .

11.

Fried DW , DeBenedetto BN , Leo JJ. Rethinking the AAMI/ISO international standard for oxygen transfer performance of artificial lungs . Perfusion 1994; 9: 335-342 .

12.

Bartlett RH. Physiology of extracorporeal life support. In Zwischenberger JB , Bartlett RH eds. Extracorporeal support in critical care, first edition. Ann Arbor, MI: Extracorporeal Life Support Organization , 1995: 27-52.

13.

Homishak M , Widmer S , Klementovich M , Cunningham J , Oblack D. Sterility of previously assembled cardio-pulmonary bypass circuits . J Extra Corpor Technol 1993; 25: 84-86 .

14.

Young WV , Heemsoth CH , Georgiafandis G , Mitchell DC , Hackett DK , Bahna DG. Extracorporeal circuit sterility after 168 hours . J Extra Corpor Technol 1997; 29: 181-184 .

15.

Horton S , Thuys C , Bennett M , Augustin S , Rosenberg M , Brizard C. Experience with the Jostra Rotaflow and Quadrox D oxygenator for ECMO . Perfusion 2004; 19: 17-23 .